Johns Hopkins Medicine Office of Continuing Medical Education
Skip Navigation.
How ToAbout CMECME CalendarOnline/EnduringProgramsResources & DownloadsContact & Travel InformationBlog
CME Online
Forgot your password?

Not Registered yet?

Create a new account.

80022908: 20th Annual Clinical Care of the Patient with HIV Infection

May 17-18, 2010
  • Download Brochure
  • Send to Colleague
  • Back to List
Click here for a text version of the brochure
Text version of brochure


20th Annual Clinical Care of the Patient with HIV Infection Brochure Cover Image


ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 13.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
OTHER CREDIT
This program has been reviewed and is acceptable for 13.00 prescribed hours by the American Academy of Family Physicians.
American Nurses Credentialing Center (ANCC)
accepts AMA PRA Category 1 credit™ by organizations accredited by the ACCME.
American Academy of Nurse Practitioners
(AANP) accepts AMA PRA Category 1 credit™ by organizations accredited by the ACCME.
American Academy of Physician assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 13 hours of Category 1 credit for completing this program. This activity has been approved for 12 credit hours by the Maryland Board of Pharmacy.

Description:
The purpose of this activity is to provide an up-to-date, state-of-the-art overview of the clinical care of patients with HIV infection for practicing clinicians and other health professionals. The activity will include discussions of HIV epidemiology, clinical management and treatment, and longitudinal care. The material will be clinically oriented with a focus on the latest pertinent data from clinical trials and basic research. Participants can expect to become more familiar with the primary care of the patient with HIV infection and the management of clinical complications of HIV disease.

Objectives:
After attending this activity, the participant will demonstrate the ability to:
• Describe and appropriately prescribe highly active antiretroviral therapy for HIV
• Describe the impact of HIV on the body’s systems
• Evaluate and manage comorbidities, including viral hepatitis, tuberculosis and sexually transmitted infections
• Describe trends and HIV management challenges as survival increases.

Talks

May 17, 2010  7:30 AM to 8:15 AM

HAART 101 (Optional Session)

Melia, Michael
To list the laboratory tests that should be checked for a patient with newly diagnosed HIV infection; To differentiate between genotypic and phenotypic testing
May 17, 2010  7:30 AM to 1:00 PM

Morning Session (Moderator)

Gallant, Joel
May 17, 2010  8:15 AM to 8:30 AM

Welcome and Conference Goals

Gallant, Joel
May 17, 2010  8:30 AM to 9:00 AM

Global Epidemiology and Biomedical Prevention

Quinn, Thomas
To discuss the spread of HIV internationally and explain the most effective interventions to limit its spread in the future
May 17, 2010  9:00 AM to 9:30 AM

Understanding HAART

Siliciano, Robert
To discuss the limits of antiretroviral therapy in controlling HIV replication
May 17, 2010  9:30 AM to 10:15 AM

Initiating HAART in 2010

Gallant, Joel
To discuss the indications for initiating antiretroviral therapy, and preferred and alternative choices for the initial regimen
May 17, 2010  10:45 AM to 11:30 AM

Clinical Case Conference I

Melia, Michael
To identify appropriate antiretroviral medication regimens for patients with different baseline medical comorbidities
May 17, 2010  10:45 AM to 11:30 AM

Clinical Case Conference I

Gallant, Joel
May 17, 2010  10:45 AM to 11:30 AM

Clinical Case Conference I

Alwood, Karla
To apply decisions made regarding HIV treatment options
May 17, 2010  10:45 AM to 11:30 AM

Clinical Case Conference I (Moderator/Case Developer)

Cofrancesco Jr., Joseph
To select ARV for HAART-naïve and early treatment patients
May 17, 2010  12:30 PM to 1:00 PM

Lunch Topic: How HIV/AIDS Has Informed Medicine

Bartlett, John
To review most important recent advances and directions in HIV research
May 17, 2010  1:30 PM to 5:00 PM

Afternoon Session - Track 1 (Moderator)

Moore, Richard
May 17, 2010  1:30 PM to 5:00 PM

Afternoon Session - Track 2 (Moderator)

Scotti, Lisa
May 17, 2010  1:30 PM to 2:00 PM

Sexually Transmitted Infections and HIV: A Case-Based Update (Track 1)

Ghanem, Khalil
To apply principles of STI diagnostics and therapeutics when managing HIV-infected patients
May 17, 2010  1:30 PM to 2:00 PM

Substance Abuse in HIV-Infected Individuals: Just Another Co-Morbid Condition? (Track 2)

Lucas, Gregory
To discuss ways in which substance abuse affects HIV care and possible strategies in this population
May 17, 2010  2:00 PM to 2:30 PM

Managing Renal Issues in HIV-Positive Patients (Track 1)

Fine, Derek
To recognize the growing prevalence and importance of kidney disease in the HIV-positive population
May 17, 2010  2:30 PM to 3:00 PM

Initial Evaluation of the HIV-Positive Patient (Track 2)

Eldred, Lois
To describe the key elements of an initial evaluation of the patient with HIV infection
May 17, 2010  2:30 PM to 3:00 PM

The Limits of Evidence-Based Medicine (Track 1)

Treisman, Glenn
To describe the current concept of evidence-based medicine; To discuss the issues of validity and reliability in clinical trials; To discuss the potential misinterpretations of clinical trials; To discuss the way exclusionary and inclusionary criteria affect trials data
May 17, 2010  3:30 PM to 4:00 PM

Cognitive Dysfunction and HIV in 2010 (Track 1)

Sacktor, Ned
To describe the clinical features, diagnosis and treatment of HIV-associated neurocognitive disorders
May 17, 2010  3:30 PM to 4:00 PM

Managing the Side Effects of HAART (Track 2)

Mancini, Cheryl
To identify and treat medication side effects so that patient may achieve a viral load of less than 50 copies/mL
May 17, 2010  4:00 PM to 4:30 PM

HPV Disease in the HIV-Infected Woman (Track 1)

Anderson, Jean
To review the association between HIV and HPV-related lower genital tract disease; To discuss the screening, treatment and follow-up of pre-invasive cervical lesions in HIV-positive women; To discuss prevention of cervical cancer issues in low-resource settings
May 18, 2010  8:30 AM to 9:15 AM

Antiretroviral Resistance and Treatment of the Experienced Patient

Gallant, Joel
May 18, 2010  8:30 AM to 12:10 PM

Tuesday, May 18 - Morning Session (Moderator)

Chaisson, Richard
May 18, 2010  9:15 AM to 9:45 AM

Drug Interactions

Andrade, Adriana
To review basic principles of drug metabolism; To review selected antiretroviral drug interactions; To summarize strategies to avoid and overcome drug interactions
May 18, 2010  9:45 AM to 10:15 AM

Managing the Middle-Aged and Older Patient with HIV

Gebo, Kelly
To discuss issues in the management of older patients
May 18, 2010  10:45 AM to 11:20 AM

Clinical Case Conference II

Gebo, Kelly
May 18, 2010  10:45 AM to 11:20 AM

Clinical Case Conference II

Andrade, Adriana
May 18, 2010  10:45 AM to 11:20 AM

Clinical Case Conference II

Lucas, Gregory
May 18, 2010  10:45 AM to 11:20 AM

Clinical Case Conference II (Moderator/Case Developer)

Moore, Richard
To present and discuss a clinical case
May 18, 2010  11:20 AM to 11:50 AM

Vitamin D Deficiency in the HIV-Infected Patient

Brown, Todd
To explain the associations between vitamin D deficiency and health outcomes; To describe the best way to evaluate and treat vitamin D deficiency
May 18, 2010  1:30 PM to 2:00 PM

Enchancing Patient-Provider Communication for Better Patient Outcomes

Beach, Mary
To communicate more effectively with patients
May 18, 2010  1:30 PM to 4:15 PM

Tuesday, May 18 - Afternoon Session (Moderator)

Mckenzie, Robin
May 18, 2010  2:00 PM to 2:30 PM

New Developments in Managing Viral Hepatitis

Thomas, David
To describe recent developments in treating HCV infection; To discuss how to stage liver disease
May 18, 2010  2:30 PM to 3:00 PM

What’s New in Tuberculosis and HIV

Chaisson, Richard
To discuss treatment and prevention of tuberculosis

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Event Information
Renaissance Harborplace Hotel
202 E. Pratt St.
Baltimore, MD
Directions

Target Audience(s)

Internists, Family Practitioners, Infectious Disease Clinicians, Nurses, Nurse Practitioners, Physician Assistants, Social Workers, Counselors

Course Director

Richard Chaisson

Course Co-Director

Joel Gallant

Contact Info

410.502.9634 or cmenet@jhmi.edu

Contact Info

General Info: 410.502.9634

Mailing Address:
Johns Hopkins University School
of Medicine
Thomas B. Turner Building
720 Rutland Avenue, Room 20
Baltimore, Maryland 21205-2195

Email Us

© 2010 Johns Hopkins University
School of Medicine | Office of Continuing Medical Education
Home | Privacy Policy | Sitemap
Managed Hosting by PEER 1
HTML to PDF conversion by ABCpdf.NET